Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Galapagos nv crawled date : 2021 - 05 - 20 save search
Global Roundup: Russia-Developed RA Drug Shows Significant Promise in Phase III Study
Published: 2021-05-20 (Crawled : 15:00) - biospace.com/
BDX | $233.88 -0.1% 0.0% 770K
|
Health Technology
|
| O: -0.41%
H: 1.51%
C: 1.3%
MIST | $1.63 -0.61% 2.96% 35K
|
Health Technology
|
| O: -0.37%
H: 2.21%
C: 0.18%
GLPG | News | $29.07 -0.03% -0.14% 75K
|
Health Technology
|
| O: 0.19%
H: 2.85%
C: 2.1%
russia drug
Global Roundup: Russia-Developed RA Drug Shows Significant Promise in Phase I...
Published: 2021-05-20 (Crawled : 14:00) - biospace.com/
BDX | $233.88 -0.1% 0.0% 770K
|
Health Technology
|
| O: -0.41%
H: 1.51%
C: 1.3%
MIST | $1.63 -0.61% 2.96% 35K
|
Health Technology
|
| O: -0.37%
H: 2.21%
C: 0.18%
GLPG | News | $29.07 -0.03% -0.14% 75K
|
Health Technology
|
| O: 0.19%
H: 2.85%
C: 2.1%
russia drug
Global Roundup: UK-Developed RA Drug Shows Significant Promise in Phase III S...
Published: 2021-05-20 (Crawled : 13:00) - biospace.com/
BDX | $233.88 -0.1% 0.0% 770K
|
Health Technology
|
| O: -0.41%
H: 1.51%
C: 1.3%
MIST | $1.63 -0.61% 2.96% 35K
|
Health Technology
|
| O: -0.37%
H: 2.21%
C: 0.18%
GLPG | News | $29.07 -0.03% -0.14% 75K
|
Health Technology
|
| O: 0.19%
H: 2.85%
C: 2.1%
drug
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.